Olympus announced the commercial launch of HANAROSTENT Esophagus TTS self-expanding metal stents (SEMS) made by M.I. Tech and distributed exclusively through Olympus in the U.S. The Through-the-Scope (TTS) esophageal stent, the newest addition to the Olympus self-expanding stent portfolio, helps to achieve luminal patency in a variety of clinical applications and is designed for use in palliative treatment of esophageal stricture and/or trachea-esophageal fistula caused by malignant tumors. The stent offers a fully covered or partially covered option. Pre-loaded into the delivery system, the HANAROSTENT Esophagus TTS fits down the working channel of a standard therapeutic gastroscope and is deployed for placement in the esophagus. The hook-and-cross nitinol design, unique to HANAROSTENT products, was designed with patient comfort in mind and enables optimal radial and axial force allowing for the flexibility to conform to a patient's anatomy and precisely target the stricture. Unlike over-the-wire esophageal stents, the new 10.5F HANAROSTENT Esophagus TTS allows for accurate and easy esophageal stenting under direct endoscopic visualization. Additional benefits of the new esophageal stent include: Minimized Use of Fluoroscopy: Direct visualization of the lumen allows physicians to place the stent with reduced dependence on fluoroscopy; Increased Procedural Efficiency: Through-the-Scope application allows for fewer scope/device exchanges, leading to increased efficiency and potential reduction of procedure time; Unique Wire Structure: Hook-and-cross nitinol design provides optimal radial and axial force aimed to minimize the impact of retrosternal pressure, which can be painful to patients; Intuitive Delivery System: Long delivery length options, ability to fully recapture stent up to a point-of-no-return, as well as a retrieval lasso for stent repositioning combine to allow for safety and precision of placement for users of all experience levels.
MITECH CO.,LTD. is a Korea-based company mainly engaged in the manufacturing and sale of stents. Stents include biliary, esophagus, pyloric, large intestine, duodenal stents, and stents for sample and study, among others. The Companyâs stents are sold under the brand names of CHOOSTENT and HANAROSTENT. In addition, the Company is engaged in the manufacture and sale of low frequency therapies, crushers and blood glucose meters. The Company distributes its products within the domestic market and to overseas markets.